"Genes, Wilms Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Genes at loci that are involved in the development of WILMS TUMOR. Included are human WT1 at 11p13 and human WT2 (MTACR1) at 11p15.
| Descriptor ID |
D016162
|
| MeSH Number(s) |
G05.360.340.024.340.375.249.420 G05.360.340.024.340.415.400.420
|
| Concept/Terms |
Genes, Wilms Tumor- Genes, Wilms Tumor
- Tumor Genes, Wilms
- Wilms' Tumor Genes
- Genes, Wilms' Tumor
- Tumor Genes, Wilms'
- Genes, Wilms
- Wilms Genes
- Wilms Tumor Genes
- Genes, Wilms'
- Genes, Wilm
- Genes, Wilm's
- Wilms' Genes
Genes, WT2 Wilms Tumor- Genes, WT2 Wilms Tumor
- MTACR1 Genes
- Gene, MTACR1
- Genes, MTACR1
- MTACR1 Gene
- WT2 Genes, Human
- Gene, Human WT2
- Genes, Human WT2
- Human WT2 Gene
- Human WT2 Genes
- WT2 Gene, Human
- Multiple Tumor-Associated Chromosome Region 1 Genes
- Multiple Tumor Associated Chromosome Region 1 Genes
|
Below are MeSH descriptors whose meaning is more general than "Genes, Wilms Tumor".
Below are MeSH descriptors whose meaning is more specific than "Genes, Wilms Tumor".
This graph shows the total number of publications written about "Genes, Wilms Tumor" by people in this website by year, and whether "Genes, Wilms Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genes, Wilms Tumor" by people in Profiles.
-
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood. 2010 Aug 05; 116(5):788-92.
-
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol. 2009 Jul 01; 27(19):3198-204.
-
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol. 2008 Oct 01; 26(28):4595-602.
-
Expanding the clinical spectrum of Frasier syndrome. Pediatr Dev Pathol. 2008 Mar-Apr; 11(2):122-7.
-
In vitro stimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide-specific T cells with in vitro and in vivo tumoricidal activity. Clin Cancer Res. 2004 Nov 01; 10(21):7207-19.
-
WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 1995 Oct 02; 14(19):4662-75.
-
Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science. 1992 Jul 31; 257(5070):674-8.